Discrimination deterring HIV testing among some high-risk populations in Indonesia, foundation says

Stigma and discrimination aimed at transgendered people and men who have sex with men in Indonesia are significant factors in deterring the groups from receiving HIV tests, the country's Inter Medika Foundation said Tuesday, the Jakarta Globe reports.

Harry Prabowo, director of the foundation, said that members of these high-risk communities should be motivated to seek voluntary counseling and testing, especially those who practice unsafe sex. He added that motivation should come from members of the community, as well as family and friends. VCT is offered at clinics run by the government and nongovernmental organizations, the Globe reports.

The Indonesian government has set aside 21 billion rupiah, or about $1.79 million, in the 2009 budget for National AIDS Commission programs. The government also expects to receive $2.18 million from international donors. Subagio MS, intergovernmental body director at the Ministry of Communication and Information Technology, said that the ministry is collaborating with the media, NGOs, local authorities, communities and religious leaders to increase HIV prevention efforts. He said the ministry is "[p]roviding education and public dialogue" about HIV/AIDS, as well as distributing information to communities. "Awareness of the problem and the willingness to be tested will help change society's attitudes," he said (Osman, Jakarta Globe, 3/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug